Former President Donald Trump has announced a significant deal aimed at reducing the prices of obesity drugs to as low as $150 a month. This move is expected to make essential medications more accessible for millions struggling with obesity, a condition that affects a large portion of the population. By lowering costs, Trump hopes to alleviate the financial burden on patients and encourage more individuals to seek treatment, ultimately promoting better health outcomes. This initiative could reshape the landscape of obesity treatment and highlight the importance of affordable healthcare.

Former President Trump has announced significant discounts on obesity drugs, a move that is set to make these medications more accessible. This is particularly important as Medicare will begin covering obesity drugs for certain patients starting next year, marking a pivotal change in healthcare policy. This initiative not only aims to combat obesity but also highlights a growing recognition of the importance of addressing weight-related health issues.

Novo Nordisk and Lilly have reached a significant pricing agreement with former President Trump regarding their weight-loss drugs. This deal is important as it aims to make these medications more accessible to those struggling with obesity, potentially improving health outcomes for many Americans. By collaborating with a high-profile figure like Trump, the companies are also drawing attention to the growing importance of weight management in public health discussions.

In a significant move, President Trump has expanded the list of critical minerals in the U.S. to include copper and metallurgical coal. This decision is crucial as it aims to bolster domestic production and reduce reliance on foreign sources, ensuring a more secure supply chain for essential materials. By recognizing the importance of these resources, the administration is taking steps to support the mining industry and promote economic growth, which could lead to job creation and increased investment in the sector.

U.S. stocks have taken a downturn as investors react to disappointing corporate earnings reports and the upcoming tariff hearing involving former President Trump. This decline highlights ongoing concerns about the economic outlook and the impact of trade policies on market stability. As companies report lower-than-expected profits, market confidence is shaken, prompting investors to reassess their strategies.

Former President Trump is set to meet with the presidents of Central Asian countries as part of a strategic effort by the U.S. to counter the growing influence of China and Russia in the region. This meeting is significant as it highlights the U.S.'s commitment to strengthening ties with Central Asia, which could lead to enhanced economic and security partnerships. By engaging with these nations, the U.S. aims to promote stability and counterbalance the geopolitical dynamics shaped by its rivals.

Jamie Dimon highlights a shift in the job market, emphasizing that for Gen Z, hard work alone isn't enough to guarantee success. He points out that the traditional path to stability, like securing a factory job in Detroit, may no longer be viable. Instead, he advocates for the importance of acquiring specific skills to thrive in today's economy. This perspective is crucial as it reflects the changing landscape of employment and the need for adaptability among younger generations.

At a recent symposium on mental health at Dartmouth, NYU professor Jonathan Haidt raised concerns about how Gen Z's brains are adapting to technology, suggesting they are 'growing around their phones' much like trees warp around tombstones. This metaphor highlights the potential negative impact of constant smartphone use on young people's mental health and cognitive development. As society becomes increasingly reliant on technology, understanding these changes is crucial for addressing the challenges faced by this generation.